Skip to main content
OpenTrials
Completed

NCT Number: NCT01761032

Gauging Of Light Dependent Experiences Through Neuroimaging (GOLDEN)

In the proposed study, the investigators will assess the brain's dopamine response to UVR light in individuals who use tanning beds both frequently and infrequently.

Completed

Looking for future studies?

Notify Me

Key information

Age range

21 year–40 year

Sex eligibility

All sexes

Study type

Observational

Primary location

UT Southwestern Medical Center at Dallas, Division on Addictions

Dallas, Texas, 75390, United States

About this study

UV radiation has recently been classified as a known human carcinogen by the US Department of Health and Human Services. Nevertheless, the voluntary exposure to sunlight continues unabated despite progressively increasing rates of ultraviolet radiation (UVR)-induced illness and death, particularly skin cancer. An increasingly common form of UVR administration is through the use of indoor tanning salons. Almost 30 million Americans, including 20% of 18-39 year olds, visit indoor tanning salons each year. Frequent and excessive tanning, despite a growing understanding by those who tan of the morbidity and mortality associated with tanning, suggests that UVR may impart rewarding effects beyond the assumed cosmetic benefits. Recent studies, in fact, have shown that up to 40% of both frequent beach and salon tanners exhibit signs and symptoms consistent with an addictive disorder, including an inability to decrease their tanning frequencies, compulsive tanning, and/or continued tanning despite adverse consequences. As the mesostriatal dopaminergic pathway plays a key role in reward and addiction, the investigators propose to extend this novel finding by directly assessing the mesostriatal dopaminergic reward pathway in compulsive and infrequent tanners. This pathway plays a key role in the experience and integration of reward and alterations in this system have been observed in addicted populations. Specifically, 1) striatal dopamine is released in response to rewarding substances and experiences, 2) striatal dopamine2/3 receptor densities are lower in cocaine, alcohol, opioid, and nicotine dependent, as well as obese, subjects, and 3) reward-induced striatal dopamine efflux has been shown to be decreased in addicted, relative to non-addicted, subjects.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Between ages 21-40
  • Tan at least twice weekly over the last year (Frequent Tanners)
  • Tan less than twice a week over the last year (Infrequent Tanners)
  • Meet modified DSM-IV criteria for Frequent Tanners

Exclusion criteria

  • Medications that effect brain functioning
  • Other medical or psychiatric disorders that may affect neural functioning.
  • Drug and Alcohol abuse or dependence
  • Pregnancy

Treatment and study plan

Tanning

Device

Participants will be placed under a tanning canopy for 4-10 minutes.

Primary outcomes

  1. Striatal dopaminergic efflux

    Time frame: Up to one hour post-administration of UVR

    Determine if UVR induces striatal dopaminergic efflux is altered in compulsive tanners.

Secondary outcomes

  1. Striatal D2 receptors

    Time frame: 90 minutes prior to UVR administration

    Basal striatal D2 receptors will be assessed in infrequent and compulsive tanners.

Sponsors and collaborators

Lead sponsor

University of Texas Southwestern Medical Center

Other

Collaborators

  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Registry information

Official study title

Dopamine Response to Ultraviolet Light in Frequent and Infrequent Tanners

Acronym: GOLDEN

Important dates

Study start
2013
Primary completion
2014
Study completion
2014
First posted
Jan 4, 2013
Registry last updated
Sep 12, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.